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Major depression disorder is a common psychiatric disease with a major economic impact on society. In many
cases, no effective treatment is available. The etiology of major depression is complex, but it is clear that the disease
is, to a large extent, determined genetically, especially among individuals with a familial history of major depression,
presumably through the involvement of multiple predisposition genes in addition to an environmental component.
As a first step toward identification of chromosomal loci contributing to genetic predisposition to major depression,
we have conducted a genomewide scan by using 628 microsatellite markers on 1,890 individuals from 110 Utah
pedigrees with a strong family history of major depression. We identified significant linkage to major depression
in males at marker D12S1300 (multipoint heterogeneity LOD score 4.6; after adjustment for multiplePp .00003
testing). With additional markers, the linkage evidence became highly significant, with the multipoint heterogeneity
LOD score at marker D12S1706 increasing to 6.1 ( after adjustment for multiple testing). This studyPp .0000007
confirms the presence of one or more genes involved in psychiatric diseases on the q arm of chromosome 12 and
provides strong evidence for the existence of a sex-specific predisposition gene to major depression at 12q22-q23.2.
Introduction
Major depression disorder (MDD) is one of the most
common psychiatric diseases, with lifetime prevalence es-
timates ranging from a minimum of 5% to a maximum
of 17% (Weissman et al. 1991; Kessler et al. 1994; Spaner
et al. 1994). As many as 15% of patients with severe
MDD die by suicide (Angst et al. 1999). The societal costs
of MDD, including costs due to treatment, morbidity, and
lost productivity, have been estimated at 1$43 billion an-
nually in the United States alone (Greenberg et al. 1993;
Pincus and Pettit 2001). According to the World Health
Organization (Murray and Lopez 1996), MDD is a major
source of disability worldwide and is predicted to become
second only to ischemic heart disease by the year 2020.
Despite this high prevalence and major economic impact
on society, little is known about the etiology of the disease.
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Adding to the problem is the observation that many peo-
ple with depression who could be treated effectively do
not seek or obtain treatment (Hirschfeld et al. 1997; Da-
vidson and Meltzer-Brody 1999).
Although epidemiological studies have demonstrated
a clear environmental component in the etiology of
MDD, genetic factors are important as well. Twin studies
have shown that there is a much higher concordance with
respect to depression-related phenotypes in MZ twins
than in DZ twins (Bertelsen et al. 1977; Torgersen 1986;
Englund and Klein 1990). In addition, many families
show clustering of MDD (Sullivan et al. 2000), suggesting
a high level of familiality. The results of segregation anal-
yses are usually inconsistent with a Mendelian mode of
inheritance (Cox et al. 1989), although other studies have
indicated the possibility of a relatively straightforward
inheritance pattern (Marazita et al. 1997).
Even though genetic predisposition to MDD is well
established, and despite the importance of the disease,
few linkage results for MDD have been reported (Tanna
et al. 1976, 1989; Craddock et al. 1994; Balciuniene et
al. 1998; Jones et al. 2002; Zubenko et al. 2002b). This
may be due to the multifactorial etiology of MDD, with
vulnerability being influenced in a complex way by both
environmental and genetic factors. In addition, the ge-
netic factors may include multiple weak- or moderate-
effect genes. One approach to overcoming these diffi-
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culties is to narrowly define the phenotype, such that the
impact of environmental influences is minimized and the
effect of fewer genes is expected. One of the most reliable
findings in the epidemiology of MDD is a two- to three-
fold female-to-male difference in population risk for
MDD (Moldin et al. 1991; Robins and Regier 1991;
Tsuang et al. 1994). This suggests that either the sporadic
rate among females is significantly higher than among
males or that the penetrance of some depression-related
genes is sex-specific. Although Kendler et al. (2001) did
not observe statistically significant differences in herita-
bility of MDD across sexes, in a large twin study it was
found that the genetic risk factors for MDD in men and
women, although positively correlated, are significantly
different. This observation was recently confirmed in an
allelic association study of recurrent, early-onset MDD
(Zubenko et al. 2002a), in which a strong sex specificity
at 16 of 19 candidate susceptibility loci was reported
(although caution should be used when applying linkage
analysis for the determination of the correct phenotype).
Highly significant linkage, using the definition proposed
by Lander and Kruglyak (1995), has recently been ob-
served by Zubenko et al. (2002b) in chromosomal region
2q33-q34 for women from families with recurrent, early-
onset MDD. For these reasons, we also incorporated sex-
specific phenotypes in the linkage analysis. Our results
provide very strong evidence for the existence of a gene,
in the chromosomal region 12q22-q23.2, that predis-
poses males to MDD.
Subjects and Methods
Subjects and Pedigrees
A study of the familial nature of disease in Utah ben-
efits from the population, which consists primarily of
members of the Church of Jesus Christ of Latter Day
Saints (LDS, or Mormons). Many Mormons abstain
from coffee, alcohol, and tobacco consumption, affect-
ing the incidence of some related diseases (e.g., Spak et
al. 2000). Family size in Utah is larger than the U.S.
average. There is also a keen interest in genealogy and
the documentation of family histories. Both family size
and genealogical records contribute to the success of
genetic studies in Utah. It has been demonstrated that
the Mormon population of Utah has northern European
gene frequencies (McLellan et al. 1984) and normal lev-
els of inbreeding (Jorde and Skolnick 1981). These char-
acteristics make this population appropriate for infer-
ences about common diseases in populations of northern
European descent.
A total of 407 pedigrees were ascertained for a family
history of MDD for this study. Among these pedigrees,
110 that contain a minimum of four affected individuals
were selected for genotyping. A Brief Screen for Psy-
chopathology (BSP) was developed by our team of cli-
nicians and was administered by clinician-trained clinic
coordinators. This tool was an adaptation of the Com-
posite International Diagnostic Interview (CIDI) (World
Health Organization 1990), modified to particularly
screen for MDD and bipolar disorder (BPD) rather than
the full spectrum of psychiatric disorders. All affected
individuals in our study met the Diagnostic and Statis-
tical Manual of Mental Disorders criteria for MDD or
BPD (American Psychiatric Association 1994). We tested
the tool for reliability against the CIDI and also per-
formed a test-retest for the BSP. We phenotyped 37 in-
dividuals with both tools, and 41 individuals were
screened twice with the BSP. For the CIDI-BSP reliability
test, we found that 95% were concordant for the phe-
notype definition we were analyzing (only two individ-
uals changed phenotype classification). In one of the two
discrepant cases, the individual responded differently to
identical questions on both tools and was called “un-
affected” by BSP and “affected” by CIDI; the difference
was thus due to intraindividual variability. The other
person had never reported any symptoms to a physician
(required in CIDI) but gave the same answers for all
questions in BSP and CIDI. He was called “affected” by
BSP and “unaffected” by CIDI. For the BSP test-retest,
95% were concordant (two individuals changed phe-
notype classification). One individual was called “un-
affected” at the first interview but 56 d later was in an
MDD episode and answered the BSP questions differ-
ently. The second individual was called “affected” by
MDD, but 2 mo later the diagnosis was changed to
generalized anxiety disorder. All phenotypes were in-
dependently assigned by at least two clinicians, after
reviewing the results from the BSP and available medical
records. If there was disagreement in phenotype assign-
ments or evidence for an alternative phenotype not
screened for comprehensively in the BSP, then the CIDI
was administered.
This study was approved by the institutional review
boards of Intermountain Health Care and Valley Men-
tal Health. Informed consent was obtained from each
participant.
MDD and BPD are clearly differentiated by the ab-
sence or presence of episodes of mania. However, it has
been shown that relatives of probands with BPD have
increased risk of MDD (Kelsoe 2003), and, in multiple
linkage studies, MDD and BPD have been included in
a broader phenotype of affective disorders. We included
individuals with BPD as “affected” in the phenotype
definition, which we will refer to throughout as “DEP.”
However, it must be pointed out that, in contrast to other
studies, the majority of affected individuals in all our
pedigrees have MDD, and the minority have type I and
type II BPD, since pedigrees in our study were ascer-
tained for MDD. Our sample set included 1,890 indi-
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Figure 1 Results of genomic search for loci linked to MDD. Multipoint HLOD scores for the dominant model are plotted on the Y-axis,
and marker positions (in cM) are plotted on the X-axis. Vertical dashed lines delimit the chromosomes, and chromosome numbers (odd numbers
only) are indicated at the top of the figure. A, HLOD for DEPM phenotype. B, HLOD for DEPF phenotype. C, HLOD for DEP phenotype.
viduals, 784 of whom are affected with recurrent MDD
(238 males and 546 females), 161 with a single episode
of MDD (48 males and 113 females), and 162 with BPD
(62 males and 100 females). The average pedigree con-
tains 17 studied individuals, 10 of whom are affected;
the pedigree size varies from 6 to 55 individuals, with
4–31 of them being affected. In total, 69% of all affected
individuals are females, and 31% are males. The average
size of pedigrees, as well as the number of affected in-
dividuals used in this study, is substantially higher than
in most other studies of psychiatric diseases.
Genotyping
DNA was extracted from blood buffy coats through
use of PUREGENE DNA isolation kits (Gentra Systems).
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Figure 2 Results of genomic search for loci linked to MDD. Multipoint HLOD scores for the recessive model are plotted on the Y-axis,
and marker positions (in cM) are plotted on the X-axis. Vertical dashed lines delimit the chromosomes, and chromosome numbers (odd numbers
only) are indicated at the top of the figure. A, HLOD for DEPM phenotype. B, HLOD for DEPF phenotype. C, HLOD for DEP phenotype.
We were able to obtain blood samples from 1,357 of
1,890 family members from 110 pedigrees (the remain-
der were either deceased or did not volunteer to partic-
ipate in the study). All samples were genotyped using
628 fluorescent dye–labeled microsatellite markers (di-,
tri-, and tetranucleotide repeats) developed at Myriad
Genetics, covering the entire genome, including the X
chromosome. The mean heterozygosity index for these
genomic search markers was ∼75%. All dinucleotide re-
peat markers contained GTTT extensions at the 5′ ends
of the unlabeled PCR primers to reduce the variability
of addition of nontemplated nucleotides at the 3′ ends
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Figure 3 Results of linkage analyses for chromosome 12, from the genomic search for loci linked to MDD. Multipoint HLOD scores for
the dominant model and DEPM phenotype are plotted on the Y-axis, and marker positions (in cM) are plotted on the X-axis. Black dots
correspond to the position of markers used in the analysis. Markers at which the strongest linkages were observed for psychiatric disorders
(see fig. 6) are indicated.
of the labeled products (Brownstein et al. 1996). PCR
products were analyzed on ABI 377 fluorescent sequenc-
ers. The average spacing between genomic search mark-
ers was 5.8 cM. The genetic map used for all analyses
was generated internally, through use of the CRI-MAP
program (Lander and Green 1987), on 3,916 meioses,
and it closely corresponds to the deCODE map (Kong
et al. 2002). After a strong linkage signal was obtained
on chromosome 12q23, 33 additional markers were
added to a 33-cM region between markers D12S303 and
D12S353. This decreased the average marker spacing in
the region to 0.9 cM. Inheritance of all alleles was ver-
ified using the PEDCHECK program (O’Connell and
Weeks 1998). Samples with incompatibilities were gen-
erally regenotyped and were set to “missing” if they
could not be resolved.
Linkage Analysis
In this study, we employed the robust multipoint link-
age statistics proposed by Go¨ring and Terwilliger (2000).
Linkage analysis was performed using MCLINK, a pro-
gram developed by Myriad Genetics, which allows anal-
ysis of very large pedigrees with any number of geno-
typed markers (Thomas et al. 2000). This analysis tool
has been successfully employed to map common disease
genes (Kort et al. 2000; Camp et al. 2001; Samuels et
al. 2001; Stone et al. 2002). Two models (dominant and
recessive) were used in the linkage analysis. A gene fre-
quency of 0.003 was chosen for the dominant model,
and a gene frequency of 0.0775 was chosen for the re-
cessive model, yielding an approximate disease preva-
lence due to a single locus of 0.6%. This disease fre-
quency is equivalent (if we assume the existence of 10
major genes with similar effects on MDD) to 6% of the
general population having heritable MDD. Only affected
individuals were considered informative for linkage. The
penetrance was chosen to be nine times higher than the
sporadic rate. This penetrance is equivalent to a fivefold
increased risk of MDD among first-degree relatives of
MDD probands, a value close to the one observed in
families ascertained through adult probands with recur-
rent MDD (Zubenko et al. 2001).
Three phenotypes were defined for our analyses: in
the first one (DEP), all affected individuals are equally
informative; in the second one (DEPF), only affected
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Figure 4 Linkage analyses of chromosomal region 12q21.1-q23.3 with additional markers (dominant model, DEPM phenotype). Black
dots correspond to the position of markers used in the analysis. The dashed line indicates the region within boundaries determined by recom-
bination events in three pedigrees with the strongest linkage evidence (see fig. 5).
females are considered informative; and, in the third one
(DEPM), only affected males are considered informative.
Although all 110 pedigrees had at least four affected
individuals with the DEP phenotype, the number of in-
formative pedigrees with the DEPF and the DEPM phe-
notypes was significantly lower: 94 pedigrees had at least
four affected individuals with the DEPF phenotype and
only 32 pedigrees had at least four affected individuals
with the DEPM phenotype.
Results
Genomewide Search
We performed a genomewide scan for loci linked to
phenotypes DEP, DEPF, and DEPM through use of a set
of 628 highly polymorphic microsatellite repeat markers.
Results of linkage analyses for the genome scans obtained
using dominant and recessive models are shown in figures
1 and 2, respectively. Because our pedigrees were multi-
generational, with several affected individuals in each gen-
eration, we did not expect to observe recessive linkage
evidence. Consistent with this expectation, no significant
recessive linkage signals were detected. However, we
found strong evidence of linkage on chromosome 12q23.1
for the DEPM phenotype at marker D12S1300 (hetero-
geneity LOD score [HLOD] 4.6) when the dominant
mode of inheritance was used. Results of linkage analyses
for chromosome 12, obtained using the dominant model,
are shown in figure 3. In this study, we used the guidelines
proposed by Lander and Kruglyak (1995) to distinguish
among “highly significant,” “significant,” and “sugges-
tive” linkage evidence (it should be mentioned that such
categorization is only approximate). However, the present
study employed three phenotypes and two models for
each of the phenotypes. Therefore, we adjusted the thresh-
olds proposed by Lander and Kruglyak (1995) to account
for performing six tests. To be conservative, we assumed
that these models and phenotypes were not correlated,
requiring an adjustment of LOD score unitslog (6)10
(∼0.8). Accordingly, we used the threshold of 5.7 for a
“highly significant” LOD score, 4.1 for “significant,” and
2.7 for “suggestive” evidence for linkage. Using these
thresholds, we can characterize the linkage evidence to
chromosome 12q23.1 obtained in the genome scan as
significant, with corresponding P value equal to .00003.
There were no other regions that reached the significant
or suggestive thresholds.
Linkage Analyses of the 12q21.1-q23.3 Region
We genotyped an additional 33 markers in the 33-cM
interval between markers D12S303 and D12S353, where
the strongest evidence for linkage was observed. The link-
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Table 1
Markers and Linkage Scores in
Chromosomal Region 12q21.1-
q23.3 (DEPM Phenotype,
Dominant Model)
Markera
Relative
Position
(cM) HLOD
D12S303 .0 .9
D12S1684 3.5 1.2
D12S1667 9.6 2.7
D12S1710 10.9 3.1
D12S1064 11.2 3.2
D12S322 11.4 3.7
D12S1345 12.9 4.2
12-MYR0285 13.6 4.0
12-MYR0255 16.6 5.1
12-MYR0256 16.7 5.1
D12S309 18.9 4.8
D12S1716 19.1 4.7
12-MYR0284 19.2 4.7
D12S1051 19.6 5.6
D12S2081 19.7 5.6
12-MYR0288 20.2 5.1
D12S1300 20.6 5.8
D12S1671 20.7 5.8
D12S1706 21.1 6.1
12-MYR0254 21.2 5.7
D12S1600 21.3 6.0
D12S346 21.6 5.7
12-MYR0289 21.8 5.3
12-MYR0283 22.3 4.9
D12S1058 22.4 4.7
D12S1588 22.6 5.4
D12S1041 23.5 4.8
12-MYR0286 23.6 4.6
12-MYR0287 24.3 4.5
D12S318 25.4 4.0
D12S1607 25.5 3.9
D12S1074 25.6 3.9
PAH 26.8 3.1
D12S338 28.1 3.1
D12S1636 29.0 2.6
D12S1335 32.0 1.3
D12S84 32.2 1.3
D12S353 33.4 1.2
a Markers denoted “12-MYR”
were developed at Myriad Genetics.
Primer sequences are available on
request.
age results (when the dominant model and DEPM phe-
notype were used) including these added markers are
shown in figure 4 and in table 1. The highest HLOD score
for the dominant model, 6.1 (corresponding P value is
equal to .0000007 after adjustment for multiple testing)
at marker D12S1706, meets the criteria for highly sig-
nificant linkage after adjustment. Linkage evidence is very
sensitive to phenotype definition: HLOD for the DEP and
DEPF phenotypes is !0.1 everywhere in the region. If only
individuals with MDD are considered affected and those
with BPD are considered uninformative, the highest
HLOD score is 4.7. This indicates, as expected, that in-
dividuals affected with MDD and BPD in our pedigrees
share the same haplotypes and that, although linkage ev-
idence comes mainly from individuals with MDD, indi-
viduals with BPD substantially increase it. It is interesting
to note that the LOD score increased sharply after more
markers were added to the region, even though we used
a higher marker density in the genome scan than in most
previously published studies. This suggests that important
regions could be missed altogether in genomic scans per-
formed with low marker density.
Discussion
In the present study, we have conducted a genomewide
search for genes predisposing to MDD and have found
highly significant linkage evidence for such a gene in the
region 12q22-q23.2. Seven of 32 pedigrees with four or
more affected male individuals show evidence of linkage
in this region (LOD 10.5). In these pedigrees, ∼86% of
affected males (excluding affected spouses) share the seg-
regating haplotypes. In comparison, only 39% of af-
fected females share these haplotypes. This clearly in-
dicates that the effect of the MDD predisposition gene
in this region is much stronger among males than among
females. We used recombination events in the three ped-
igrees showing the strongest linkage evidence (pedigree
multipoint LOD 11.5) to determine the boundaries of
the region. Individuals with these recombinants were af-
fected with MDD. However, it should be mentioned that
the use of recombination events for the determination
of the region’s boundaries is tentative, especially given
the fact that only 86% of affected males within linked
pedigrees share the segregating haplotypes. By requiring
at least two different recombination events per bound-
ary, we were able to narrow the region to 6.5 Mb, be-
tween markers 12-MYR0256 and D12S1607 (fig. 5).
There is strong supporting evidence for the presence
of a gene involved in psychiatric disorders in this region.
Significant (Jones et al. 2002) and suggestive (Craddock
et al. 1994) linkages were obtained between the Darier
disease gene (ATP2A2) at 12q23-q24.1 and major af-
fective disorder (a mixture of MDD and BPD cases).
Moreover, there is strong support for this region from
studies of other psychiatric diseases, especially from
BPD. Observations of linkage evidence in chromosomal
region 12q23-q24 are displayed in figure 6 (some of
which are from published abstracts, not yet reported
in peer-reviewed journals). In a review article, Detera-
Wadleigh et al. (1999) described highly significant link-
age obtained in an unpublished report by Barden et al.,
for BPD at D12S366. Significant linkage evidence was
observed by Ewald (2002) for BPD at D12S1639 and
by Fullerton et al. (2003) for neuroticism at D12S346.
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Figure 5 Recombinations in three pedigrees with the strongest linkage evidence (11.5 LOD score units) to chromosomal region 12q22-
q23.2. Four affected males share the haplotype with recombination at marker D12S1607 in pedigree 101. One affected male shares the haplotype
with recombination at marker D12S1607 in pedigree 102. Three affected males share the haplotype with recombination at marker 12-MYR0256
in pedigree 102. One affected male shares the haplotype with recombination at marker 12-MYR0287 in pedigree 103. Two affected males
share the haplotype with recombination at marker D12S309 in pedigree 103.
Suggestive linkage evidence for BPD was obtained by
Morissette et al. (1999) at D12S84, Degn et al. (2001)
at D12S342, Ekholm et al. (2001) at PAH, and Maziade
et al. (2002) at IGF1. In their review article, Detera-
Wadleigh et al. (1999) described suggestive linkage for
BPD obtained in an unpublished report by McQuil-
lin et al. at D12S342. Suggestive linkage evidence for
schizophrenia was obtained by Brzustowicz et al. (2000)
at PAH and by Wilcox et al. (2002) at D12S1300.
All of these studies (including the present study) re-
vealed evidence for linkage within a 30-Mb region;
however, it is not yet possible to conclude whether a
single gene or multiple genes are responsible for all of
these observations. There are certain characteristics that
distinguish our study from the others. First, while the
strongest linkage evidence obtained in the studies men-
tioned above (including ours) appears within a relatively
small region, our strongest linkage evidence is closer to
the centromere. Second, there is a distinct difference in
the phenotype considered in the present study compared
with other studies. Although, in the majority of genetic
studies of BPD, individuals with recurrent MDD are
also considered affected, individuals with BPD consti-
tute the majority of the affected individuals. In our
study, on the other hand, individuals affected with BPD
constituted !15% of all affected individuals. This dif-
ference originates from the ascertainment of pedigrees.
In our study, all probands were affected with MDD,
whereas, in genetic studies of BPD, all probands are
affected with BPD. In addition, 15% of the affected
individuals in our study had only a single episode of
MDD. These individuals are usually not included in
genetic studies of even the broad phenotype of BPD and
recurrent MDD. The similarity of the affected individ-
uals used in this study as compared with schizophrenia
studies is even lower. Schizophrenia and MDD are gen-
erally considered to be caused by different genetic fac-
tors. Individuals with MDD typically are not considered
affected in schizophrenia studies (with one notable ex-
ception: Blackwood et al. [2001]). The third distinct
difference from other studies of psychiatric disorders in
which linkage in chromosomal region 12q23-q24 was
observed is the use of sex-specific phenotypes. Linkage
evidence obtained in the present study is very sensitive
to phenotype definition, since no evidence for linkage
was observed when either the DEP or the DEPF phe-
notypes were used.
Linkage evidence for a predisposition gene was ob-
served only for the DEPM phenotype and points to a
deleterious allele (or alleles) predisposing only males to
develop MDD and sometimes BPD. However, linkage
evidence can be deceiving. Even a moderately complex
relation between genotypes and phenotypes can sup-
press LOD scores. For example, the gene detected in
this study might have an effect on females as well, but
the effect (penetrance) may be much weaker than for
males. It is also possible that the effect of this gene is
sex-independent but that the environmental effect on
females (sporadic rate) is stronger than on males or that
other genes might have a stronger effect on females. For
example, Zubenko et al. (2002b) reported highly sig-
nificant linkage on chromosomal region 2q33-q35 ex-
clusively among females within families with recurrent,
early-onset MDD. It is also possible that the gene we
have detected has a very strong sex-specific effect on
MDD. Only with the discovery of the disease-causing
allele(s) can we provide a certain answer regarding the
role of this gene in male and female depression. What-
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Figure 6 A map of chromosomal region 12q22-q24, showing relevant markers for different psychiatric diseases and corresponding linkage
evidence. Markers and references are as follows: D12S1300 (Wilcox et al. 2002); D12S1706 (present study); D12S346 (Fullerton et al. 2003);
IGF1 (Maziade et al. 2002); PAH (Brzustowicz et al. 2000; Ekholm et al. 2001); D12S84 (Morissette et al. 1999); ATP2A2 (Craddock et al.
1994; Jones et al. 2002); D12S366 (Barden et al., cited by Detera-Wadleigh et al. 1999); D12S342 (McQuillin et al., cited by Detera-Wadleigh
et al. 1999; Degn et al. 2001), D12S1639 (Ewald 2002). The P value of .001 corresponds to a LOD score of 2.4, and the P value of .00002
corresponds to LOD score of 4.0.
ever the reason, overall haplotype sharing among af-
fected females was substantially lower than among af-
fected males, and the HLOD scores for the phenotypes
DEP and DEPF were not significant.
In conclusion, our results strongly suggest the pres-
ence of an MDD predisposition gene on chromosome
12q22-q23.2. This gene has an especially important ef-
fect on MDD among males. This represents, to our
knowledge, the first highly significant linkage evidence
of a male-specific MDD gene.
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